Emphasis
The emphasis is on: simulation and development of new detector materials and methods of detection for nuclear imaging; collimators and other selective signal modulators, and readout methods that enhance the signal quality of detecting isotope emissions; designs of novel camera geometries for dedicated, general or multi-purpose imaging; and correction methods that compensate for the radiation physics properties to improve the clinical reliability of the image (reconstructions algorithms). Of interest are improvements in collimation and camera designs for SPECT, improvements and corrections for interaction events in PET detectors, enhancement to time of flight (TOF) PET image generation methods, reproducible and standardized quantification as well as new detector materials.
Relevance
The emphasized topics are meant to lead toward: improved clinical SPECT and PET cameras or next-generation camera systems; novel simulations, reconstruction algorithms, or artifact corrections for enhancing diagnostic images; and multi-modal camera designs. Investigating the associated dosimetry estimations leads to decreased risk in diagnostic imaging studies in patients.
Examples of emphasis
- evaluation of new semiconductor, scintillation and other novel radiation detectors
- replacing photomultiplier tubes with novel photoconversion techniques
- readout electronics for measuring radiation interactions
- techniques for improved camera spatial resolution and sensitivity
- new approaches for improving coincidence measurements for TOF-PET
- application of secondary emissions (e.g. bremsstrahlung, Cherenkov) for imaging
- novel camera designs applicable to dedicated imaging of specific organs
- combining modalities for clinically relevant hybrid systems (e.g. coupling SPECT and PET to x-ray/ultrasound CT and/or to MRI or other modalities)
- software algorithms and imaging protocols to estimate patient dosimetry
- design of improved spatial and temporal resolution SPECT systems
- methods of measuring and correcting for patient motion
- new diagnostics applied to image-guided therapy and theranostics
Notes
- clinical application of image-guided therapy and theranostics is supported by the Image-Guided Interventions program
- development of novel imaging molecular agents is supported by the Molecular Imaging program
- novel evaluation of images
Notice of Special Interest in Radiation Monitoring for Trauma Care
Related News
With their eclectic mix of mutations, tumors often survive drug treatment. In a new study, researchers found a way to use cancer’s evolutionary potential against it, destroying drug-resistant tumors in animals.
A team of researchers from Johns Hopkins University recently investigated how skin tone affects the visibility of breast cancer targets in photoacoustic imaging. They found that that a new imaging technique reduces skin tone bias, improving visibility across diverse skin tones. Source: The International Society for Optics and Photonics.
A team of researchers at Vanderbilt University has developed a system of artificial cilia capable of monitoring mucus conditions in human airways to better detect infection, airway obstruction, or the severity of diseases like Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Diseases (COPD) and lung cancer. The lead researcher was funded by an NIH/NIBIB Trailblazer Award. Source: Vanderbilt School of Engineering
In a study published in Small, researchers at the University of Rochester outline a new method for using ultrathin membranes to easily identify extracellular vesicles for rapid liquid biopsies. The method, called catch and display for liquid biopsy (CAD-LB), holds promise for diagnosing cancer quickly and affordably, and assessing the progress of therapies used to treat diseases. Source: University of Rochester News
Metastasis remains the primary challenge to reducing cancer deaths worldwide. Now, a study by Memorial Sloan Kettering, published in Nature is providing unique insights into metastasis that researchers say point to new therapeutic opportunities. Source: Memorial Sloan Kettering Cancer Center News